Table 3.

Details of analysis of variance of RHI pharmacokinetics after its ODP vs subcutaneous delivery

		Sum of Squares	df	Mean Square	F	P
C max, pmol/L	Between Groups	0.39	1	0.39	0.99	0.34
	Within Groups	5.95	15	0.40
	Total	6.34	16
AUClast, pmol/L·min	Between Groups	11 348	1	11 348	0.29	0.60
	Within Groups	580 066	15	38 671
	Total	591 414	16
T max, min	Between Groups	32 736	1	32 736	3.45	0.08
	Within Groups	142 288	15	9486
	Total	175 024	16